Delivery Order SPE2DR25D2002-SPE2DR26FBSP4
- Not listed
- The Defense Logistics Agency awarded a $5,501.30 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The order is a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,650.39 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Provocholine inhalation solution in 18 mL packs. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationship with DLA and is scheduled for completion by August 28, 2025. The product will be delivered to the contractor's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $7,459.23 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with an ultimate completion date of November 4, 2025. This contract was competitively awarded without set-aside designation and utilizes firm fixed price pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Provocholine Inhalation Solution in 18ml pack quantities, with a contract ceiling value of $9,767.18. This non-competitive delivery order represents a firm fixed price transaction with a completion date of October 24, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,503.90 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs. This delivery order, issued on July 19, 2025, with an ultimate completion date of July 21, 2025, operates under a firm fixed price structure with no set-aside designation. The award represents a competitive procurement action through the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency (DLA) awarded a $2,200.52 delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML pack quantities. This is a firm fixed price, competitively awarded contract with no set-aside designation, with an ultimate completion date of September 4, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,388.80 to AmerisourceBergen Drug Corp for Provocholine inhalation solution in 18ML packs, with performance completion targeted for November 19, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for Provocholine inhalation solution in 18mL packs, with a ceiling value of $7,016.62 and a firm fixed price structure. The order is scheduled for completion by September 24, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Provocholine Inhalation Solution in 18ML packs, with a ceiling value of $2,601.79. This competitive award, made without a set-aside designation, represents a firm fixed-price delivery order for pharmaceutical products to support federal medical procurement needs. The order is expected to be completed by August 27, 2025, with performance taking place at AmerisourceBergen's...
- This delivery order, valued at $2,423.36, awards AmerisourceBergen Drug Corp the supply of Provocholine inhalation solution in 18ML packs. The contract was competitively awarded without a set-aside designation on September 22, 2025, with an ultimate completion date of September 23, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. The Defense Logistics Agency, which serves as the funding federal agency, utilizes this delivery order...
- SPE2DR25D2002Indefinite Delivery Contract
- SPE2DR25D2002-SPE2DR26FBSP4Delivery Order
The Defense Logistics Agency awarded a $1,809.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Provocholine inhalation solution in an 18-milliliter pack, with a completion date of December 12, 2025. This non-set-aside competitive award represents a single delivery order positioned as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, supplying an extensive portfolio of medications and medical supplies to support military and veteran healthcare systems. This delivery order fulfills pharmaceutical supply needs through AmerisourceBergen's comprehensive global pharmaceutical support agreement with the Defense Logistics Agency. Provocholine is a diagnostic agent used in bronchial challenge testing and represents the type of specialized pharmaceutical commodity regularly procured through the company's prime vendor relationship. The award underscores AmerisourceBergen's established capability to deliver time-sensitive medical products competitively and efficiently to support Defense Health Agency operations and broader military healthcare requirements worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/10/25 |